A
$ Value
$0
Shares
12,050
Price
$0
Filed
Jun 13
Insider
Name
Freedland Cory S.
Title
—
CIK
0001832569
Roles
Director
Transaction Details
Transaction Date
2025-06-12
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,050
Footnotes
The option vests as to 1/12 of the total shares monthly beginning July 12, 2025 until the option is fully vested on June 12, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Filing Info
Other Insiders at NGNE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BAFFI ROBERT | — | — | 2026-02-20 |
| PALEKAR ROHAN | — | — | 2026-02-20 |
|
Cvijic Christine Mikail
President and CFO
|
— | $260K | 2026-03-26 |
|
McMinn Rachel
Chief Executive Officer
|
— | $74K | 2026-03-26 |
| Noonberg Sarah B. | — | — | 2026-02-20 |
| Freedland Cory S. | — | — | 2026-02-20 |
|
Jordan Julie
Chief Medical Officer
|
— | $18K | 2026-03-26 |
|
Cobb Stuart
Chief Scientific Officer
|
— | $141K | 2026-03-13 |
| Woods Keith | — | — | 2026-02-20 |